Skip to main content
. Author manuscript; available in PMC: 2018 Dec 1.
Published in final edited form as: J Genet Couns. 2017 Mar 29;26(6):1197–1212. doi: 10.1007/s10897-017-0095-6

Table 3.

Agreement with policy by survey and small group votinga

Small group 1 (n=8)
n (%)
Small group 2 (n=8)
n (%)
Small group 3 (n=6)
n (%)
Small group 4 (n=8)
n (%)
Small group 5 (n=7)
n (%)
Small group 6 (n=5)
n (%)
Small group 7 (n=6)
n (%)
Small group 8 (n=6)
n (%)
Small group 9 (n=5)
n (%)
Small group 10 (n=7)
n (%)
Medically Actionable
 Pre-DD Survey 6 (85.7) 8 (100.0) 6 (100.0) 7 (87.5) 7 (100.0) 4 (80.0) 6 (100.0) 6 (100.0) 4 (80.0) 5 (71.4)
 Vote 1 2 (25.0) 8 (100.0) 6 (100.0) 6 (75.0) 7 (100.0) 0 (0.0) 6 (100.0) 6 (100.0) 5 (100.0) 7 (100.0)
 Vote 2 1 (12.5) 8 (100.0) 6 (100.0) 2 (25.0) 7 (100.0) 0 (0.0) 5 (83.3) 6 (100.0) 5 (100.0) 7 (100.0)
 Post-DD Survey 3 (37.5) 7 (87.5) 6 (100.0) 5 (62.5) 7 (100.0) 5 (100.0) 6 (100.0) 6 (100.0) 4 (100.0) 7 (100.0)
 Follow-up Survey 6 (85.7) 7 (100.0) 4 (66.7) 8 (100.0) 6 (85.7) 5 (100.0) 6 (100.0) 6 (100.0) 5 (100.0) 7 (100.0)
Adult Onset Conditions
 Pre-DD Survey 0 (0.0) 1 (12.5) 0 (0.0) 1 (12.5) 0 (0.0) 1 (20.0) 0 (0.0) 0 (0.0) 1 (20.0) 2 (28.6)
 Vote 1 1 (12.5) 2 (25.0) 5 (83.3) 3 (37.5) 1 (14.3) 4 (80.0) 2 (33.3) 3 (50.0) 2 (40.0) 6 (85.7)
 Vote 2 1 (12.5) 2 (25.0) 6 (100.0) 3 (37.5) 0 (0.0) 4 (80.0) 1 (16.7) 3 (50.0) 2 (40.0) 6 (85.7)
 Post-DD Survey 2 (28.6) 2 (25.0) 6 (100.0) 4 (50.0) 0 (0.0) 3 (60.0) 1 (16.7) 2 (33.3) 2 (40.0) 6 (85.7)
 Follow-up Survey 1 (14.3) 3 (42.9) 0 (0.0) 1 (12.5) 2 (28.6) 1 (25.0) 1 (16.7) 2 (33.3) 2 (40.0) 2 (33.3)
Carrier Status
 Pre-DD Survey 1 (12.5) 0 (0.0) 0 (0.0) 1 (12.5) 1 (14.3) 1 (20.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
 Vote 1 0 (0.0) 1 (12.5) 1 (16.7) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 5 (83.3)
 Vote 2 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 5 (83.3)
 Post-DD 2 (25.0) 0 (0.0) 3 (50.0) 4 (50.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (25.0) 5 (71.4)
 Follow-up Survey 0 (0.0) 1 (14.3) 1 (16.7) 1 (12.5) 0 (0.0) 1 (20.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (14.3)
a

Valid percent as not all participants responded to every question. See Table 2 for descriptions of each of the three proposed policies.